首页 › 基金 › Commodore Capital LP › IKT

Commodore Capital LP 对 IKT 的持仓历史

INHIBIKASE THERAPEUTICS INC · 医疗保健

Commodore Capital LP 在 Q2 2026 的 13F 申报中披露持有 IKT(INHIBIKASE THERAPEUTICS INC)5,397,488 股,市值约 US$11.0M,约占其申报组合的 0.65%,在其申报持仓中市值排名第 27 位。 Commodore Capital LP 最近 7 个申报季度中有 7 个季度披露了 IKT 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q2 2026)5.40M 股
申报持仓市值$10.96M
组合权重0.65%
首次申报Q4 2024
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Commodore Capital LP 对 IKT 的持仓演变

Commodore Capital LP 于 Q4 2024 首次披露 IKT 持仓:5,925,000 股(约 US$19.3M)。 在 7 次申报中,Commodore Capital LP 1 次增持、1 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 5,397,488 股、市值约 US$11.0M。

逐季持仓明细

季度股数金额变化
Q4 2024 5.92M $19.26M 新进
Q1 2025 5.34M $11.70M 减持
Q2 2025 5.40M $10.53M 增持
Q3 2025 5.40M $8.74M 持有
Q4 2025 5.40M $11.06M 持有
Q1 2026 5.40M $9.07M 持有
Q2 2026 5.40M $10.96M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IKT 与 13F 数据

IKT(INHIBIKASE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 69 只申报持有 IKT,申报仓位最大的包括:Sands Capital Alternatives, LLC (US$26.4M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IKT 的基金

查看 IKT 的全部基金持有人 →

常见问题

How long has Commodore Capital LP held IKT?

Commodore Capital LP has disclosed IKT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Commodore Capital LP's current position in IKT?

As of Q2 2026, Commodore Capital LP holds 5.40M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $10.96M, representing 0.65% of its reported portfolio and ranking #27.

Has Commodore Capital LP been buying or selling IKT?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.